CASSAVA SCIENCES INC.
25.34
07-November-24 15:59:57
15 minutes delayed
Stocks
-1.23
-4.63%
Today's range
24.64 - 27.16
ISIN
N/A
Source
NASDAQ
-
Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates
28 Feb 2022 16:03:00 By Nasdaq GlobeNewswire
-
FDA Denies Citizen Petitions Filed on Behalf of Short Selling Clients
10 Feb 2022 16:07:38 By Nasdaq GlobeNewswire
-
23 Dec 2021 09:00:00 By Nasdaq GlobeNewswire
-
Science Journal Finds No Evidence to Support Claims of Data Manipulation in 2005 Publication
21 Dec 2021 09:30:00 By Nasdaq GlobeNewswire
-
18 Nov 2021 09:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Reports Third Quarter 2021 Financial Results
10 Nov 2021 09:00:01 By Nasdaq GlobeNewswire
-
04 Nov 2021 09:30:00 By Nasdaq GlobeNewswire
-
06 Oct 2021 08:30:00 By Nasdaq GlobeNewswire
-
22 Sep 2021 08:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference
09 Sep 2021 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Releases a Public Statement Regarding Recent Allegations
03 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
-
27 Aug 2021 11:31:59 By Nasdaq GlobeNewswire
-
Cassava Sciences Responds to Allegations
25 Aug 2021 06:00:00 By Nasdaq GlobeNewswire
-
24 Aug 2021 08:15:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Reports Second Quarter 2021 Financial Results
03 Aug 2021 08:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Conference Call for Second Quarter Financial Results
02 Aug 2021 19:54:18 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer’s Disease
29 Jul 2021 09:53:35 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease
29 Jul 2021 09:53:30 By Nasdaq GlobeNewswire
-
26 Jul 2021 08:30:00 By Nasdaq GlobeNewswire
-
21 Jul 2021 08:30:00 By Nasdaq GlobeNewswire